Document Detail

Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs.
MedLine Citation:
PMID:  22525201     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND AIM: Clinical characteristics of resistant hypertensive patients in comparison to controlled patients have not been fully investigated in large cohorts. The aim of the study was to evaluate clinical differences, target organ damage and ambulatory blood pressure monitoring in resistant hypertensive patients and patients controlled on three or less drugs.
METHODS: In December 2010, from the Spanish Ambulatory Blood Pressure Monitoring Registry, we identified 14 461 patients fulfilling criteria of resistant hypertension and 13 436 hypertensive patients controlled on three or less drugs. Clinical characteristics were compared between these two groups.
RESULTS: Compared to controlled patients, those having resistant hypertension were older, more obese and had longer hypertension duration. They also had more frequently diabetes, dyslipidemia, reduced renal function, microalbuminuria, left-ventricular hypertrophy and previous history of cardiovascular events. In multivariate analyses, hypertension duration, obesity, abdominal obesity, left-ventricular hypertrophy, reduced estimated glomerular filtration rate, and microalbuminuria were independently associated with resistant hypertension. Resistant hypertensive patients had higher ambulatory blood pressures, but differences between office and ambulatory blood pressure (white-coat effect) were also more pronounced in this group, revealing a proportion of 40% of patients with normal 24-h blood pressure. On the contrary, values of 24-h blood pressure above 130 and/or 80 mmHg (masked hypertension) were present in 31% of apparently controlled patients.
CONCLUSION: Resistant hypertension is associated with obesity, longer hypertension duration and kidney and cardiac damage. Ambulatory blood pressure monitoring reveals that white-coat hypertension is common among resistant hypertensive patients, as well as is masked hypertension among apparently controlled patients.
Alejandro de la Sierra; José R Banegas; Anna Oliveras; Manuel Gorostidi; Julián Segura; Juan J de la Cruz; Pedro Armario; Luis M Ruilope
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of hypertension     Volume:  30     ISSN:  1473-5598     ISO Abbreviation:  J. Hypertens.     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-11     Completed Date:  2012-08-31     Revised Date:  2012-12-07    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  1211-6     Citation Subset:  IM    
Department of Internal Medicine, Hospital Mutua Terrassa, University of Barcelona, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / administration & dosage,  therapeutic use*
Blood Pressure
Drug Therapy, Combination
Hypertension / drug therapy*,  physiopathology
Middle Aged
Reg. No./Substance:
0/Antihypertensive Agents
Comment In:
J Hypertens. 2012 Nov;30(11):2241-2; author reply 2242-2243   [PMID:  23052050 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphi...
Next Document:  Workplace social capital and risk of chronic and severe hypertension: a cohort study.